The impact of ethambutol optic toxicity on treatment of MDR TB Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010
An incidence of the ethambutol-induced optic neuropathy and the usefulness of periodic visual acuity test – A questionnaire survey in Japan Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Vestibular toxicity, an unusual side effect of isoniazid Source: Eur Respir J 2005; 26: Suppl. 49, 455s Year: 2005
TB picture card and colour coded prescribers chart: a novel aid in the treatment of tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 303s Year: 2006
Assessment of airway collapse in adult trachobronchomalacia: Correlating subjective visual quantification and colour histogram mode technique Source: Annual Congress 2010 - Airway patency: the role of interventional bronchoscopy Year: 2010
Hearing loss in patients on treatment for drug-resistant tuberculosis Source: Eur Respir J 2012; 40: 1277-1286 Year: 2012
Pre-chemotherapy drug sensitivity test for antitubercular drugs in India – is it essential? Source: Eur Respir J 2005; 26: Suppl. 49, 649s Year: 2005
The side-effects of TB therapy: myth and reality Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties Year: 2005
Novel drugs against tuberculosis: a clinician's perspective Source: Eur Respir J 2015; 45: 1119-1131 Year: 2015
Bedaquiline: 10?years later, the drug susceptibility testing protocol is still pending Source: Eur Respir J 2015; 45: 317-321 Year: 2015
Time frame sensitivity of a point-of-care test to monitor isoniazid adherence in TB treatment Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
An audit of adherence to antituberculous drugs using a new, rapid, point of care test for isoniazid metabolites Source: Eur Respir J 2002; 20: Suppl. 38, 566s Year: 2002
First experience with novel molecular diagnostic method for detection of M. tuberculosis and rifampicin resistance Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006
Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003
Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter? Source: Eur Respir J 2007; 29: 347-351 Year: 2007
Genotypic and phenotypic M. tuberculosis resistance: guiding clinicians to prescribe the correct regimens Source: Eur Respir J, 50 (6) 1702292; 10.1183/13993003.02292-2017 Year: 2017
The low-level laser irradiation as the way to increase the antituberculous activity of isoniazid and streptomycin Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008
Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis Source: Eur Respir J , 49 (4) 1602215; DOI: 10.1183/13993003.02215-2016 Year: 2017
Modern molecular direct tests for rapid identification and drug susceptibility testing of Mycobacterium tuberculosis Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis Year: 2012